Askim
Sweden
12
2025-07-31
The entities that hold a legal rights for patent applications filed by inventor Bergh Niklas:
Niklas Bergh from Askim, SE has applied for patents for these inventions. The list has both pending applications and granted patents:
VALPROIC ACID FOR THE TREATMENT OR PREVENTION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESS FIBRIN DEPOSITION AND/OR THROMBUS FORMATION
#2 | 2023-11-16COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESS FIBRIN DEPOSITION AND/OR THROMBUS FORMATION
#3 | 2023-04-20Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof
#4 | 2023-03-30COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS
#5 | 2022-12-22Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation
#6 | 2021-03-04COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS
#7 | 2020-06-11COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESS FIBRIN DEPOSITION AND/OR THROMBUS FORMATION
#8 | 2019-04-18Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof
#9 | 2019-01-17Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation
#10 | 2018-06-28Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation
#11 | 2017-01-26COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS
#12 | 2014-02-20COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS
659202 ⎘